Clinical Trial

Effects of Substance P on Headache Induction in Healthy Individuals

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated October 15, 2024 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
Substance P is a signaling molecule that has been implicated in the pathogenesis of headache. This study aims to ascertain whether administration of substance P can induce headache in healthy adults.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-10-06.
Trial Details
NCT Number NCT06632080
Lead Sponsor Danish Headache Center
Conditions Healthy Volunteers Only
Enrollment 21 participants
Start Date 2024-10-14
Primary Completion 2025-12-31 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-10-15